Proof of principle PET imaging experiments with [18F]3, on a prostate tumor model injected with a tetrazine-coupled PSMA antagonist 10 min before radiotracer injection, allowed clear visualization of the tumor tissue, due to the 18F-labeled conjugate formed by the IEDDA reaction. Here, FOLH1 is linked to prostate neoplasm.